102 related articles for article (PubMed ID: 16471040)
21. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
22. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
[TBL] [Abstract][Full Text] [Related]
24. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M
Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A
APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
28. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
[TBL] [Abstract][Full Text] [Related]
29. EphB1 is underexpressed in poorly differentiated colorectal cancers.
Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
31. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.
Li T; Yang W; Li M; Byun DS; Tong C; Nasser S; Zhuang M; Arango D; Mariadason JM; Augenlicht LH
Mol Nutr Food Res; 2008 Nov; 52(11):1289-99. PubMed ID: 18435490
[TBL] [Abstract][Full Text] [Related]
32. [Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in colorectal cancer].
Jelski W; Orywal K; Kedra B; Szmitkowski M
Pol Merkur Lekarski; 2008 Jun; 24(144):506-10. PubMed ID: 18702331
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
[TBL] [Abstract][Full Text] [Related]
34. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
36. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
Zhang N; Ding YQ; Liang L
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
38. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression.
Milicevic Z; Bogojevic D; Mihailovic M; Petrovic M; Krivokapic Z
Int J Oncol; 2008 Jun; 32(6):1169-78. PubMed ID: 18497978
[TBL] [Abstract][Full Text] [Related]
40. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer.
Prutki M; Poljak-Blazi M; Jakopovic M; Tomas D; Stipancic I; Zarkovic N
Cancer Lett; 2006 Jul; 238(2):188-96. PubMed ID: 16111806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
